12/17
05:00 pm
atr
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Low
Report
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
12/6
10:24 pm
atr
Has AptarGroup's Share Price Slide Created a New Opportunity in 2025? [Yahoo! Finance]
Low
Report
Has AptarGroup's Share Price Slide Created a New Opportunity in 2025? [Yahoo! Finance]
12/6
01:33 pm
atr
AptarGroup (ATR): Revisiting Valuation After Mixed 2024 Performance and Recent Share Price Rebound [Yahoo! Finance]
Low
Report
AptarGroup (ATR): Revisiting Valuation After Mixed 2024 Performance and Recent Share Price Rebound [Yahoo! Finance]
12/4
05:00 pm
atr
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
Low
Report
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
12/1
05:23 pm
atr
Aptar acquires oral dosing pharma packaging solutions provider Sommaplast [Seeking Alpha]
Low
Report
Aptar acquires oral dosing pharma packaging solutions provider Sommaplast [Seeking Alpha]
12/1
05:00 pm
atr
Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions
Low
Report
Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions
11/26
02:02 pm
atr
AptarGroup (NYSE:ATR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
AptarGroup (NYSE:ATR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
07:20 am
atr
AptarGroup (NYSE:ATR) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
AptarGroup (NYSE:ATR) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
11/14
01:10 pm
atr
AptarGroup (NYSE:ATR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
AptarGroup (NYSE:ATR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
11/11
05:00 pm
atr
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
Low
Report
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
11/3
08:09 am
atr
AptarGroup (NYSE:ATR) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
Low
Report
AptarGroup (NYSE:ATR) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
11/3
08:05 am
atr
AptarGroup (NYSE:ATR) was given a new $133.00 price target on by analysts at Wells Fargo & Company.
Low
Report
AptarGroup (NYSE:ATR) was given a new $133.00 price target on by analysts at Wells Fargo & Company.
11/3
08:03 am
atr
AptarGroup (NYSE:ATR) had its price target lowered by analysts at Robert W. Baird from $160.00 to $145.00. They now have an "outperform" rating on the stock.
Low
Report
AptarGroup (NYSE:ATR) had its price target lowered by analysts at Robert W. Baird from $160.00 to $145.00. They now have an "outperform" rating on the stock.
10/31
11:27 pm
atr
AptarGroup (ATR) Margin Jump Reinforces Bulls as Future Growth Outlook Softens [Yahoo! Finance]
Medium
Report
AptarGroup (ATR) Margin Jump Reinforces Bulls as Future Growth Outlook Softens [Yahoo! Finance]
10/30
08:12 pm
atr
AptarGroup (ATR) Q3 Earnings and Revenues Top Estimates [Yahoo! Finance]
Low
Report
AptarGroup (ATR) Q3 Earnings and Revenues Top Estimates [Yahoo! Finance]
10/30
05:47 pm
atr
AptarGroup Non-GAAP EPS of $1.62 beats by $0.05, revenue of $961.13M beats by $9.25M [Seeking Alpha]
Low
Report
AptarGroup Non-GAAP EPS of $1.62 beats by $0.05, revenue of $961.13M beats by $9.25M [Seeking Alpha]
10/30
05:27 pm
atr
Aptar Reports Third Quarter 2025 Results [Yahoo! Finance]
Low
Report
Aptar Reports Third Quarter 2025 Results [Yahoo! Finance]
10/30
05:00 pm
atr
Aptar Reports Third Quarter 2025 Results
Medium
Report
Aptar Reports Third Quarter 2025 Results
10/25
11:32 pm
atr
AptarGroup (ATR): A Fresh Look at Valuation Following Recent Share Price Decline [Yahoo! Finance]
Low
Report
AptarGroup (ATR): A Fresh Look at Valuation Following Recent Share Price Decline [Yahoo! Finance]
10/18
10:11 pm
atr
AptarGroup (NYSE:ATR) Is Paying Out A Larger Dividend Than Last Year [Yahoo! Finance]
Low
Report
AptarGroup (NYSE:ATR) Is Paying Out A Larger Dividend Than Last Year [Yahoo! Finance]
10/16
08:00 am
atr
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
Low
Report
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
10/15
05:25 pm
atr
Aptar Named Among Top 100 of the ‘World's Top Companies for Women 2025' by Forbes [Yahoo! Finance]
Low
Report
Aptar Named Among Top 100 of the ‘World's Top Companies for Women 2025' by Forbes [Yahoo! Finance]
10/15
05:00 pm
atr
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
Low
Report
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
10/12
11:21 am
atr
If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity [Yahoo! Finance]
Low
Report
If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity [Yahoo! Finance]
10/3
03:30 pm
atr
AptarGroup (NYSE:ATR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
AptarGroup (NYSE:ATR) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.